The updates below provide the latest verified information.
FMD ICC Priorities for Engagement
- Regulatory: immediate resolution required to finalise Section 9 and Section 10, to be concluded through an urgent joint technical workshop.
Updates
- Vaccine
- 2.1 Biogénesis Bagó
- 2.2 Dollvet
- National operational coordination: vaccine rollout dashboard
1. Regulatory
All outstanding input and feedback on Section 9 and Section 10 must be resolved urgently so that final versions can be submitted to the Minister for publication by 17 April 2026.
The FMD ICC will send a letter to the Joint Working Group with proposed dates for a joint technical workshop with the Department of Agriculture and the MTT.
All outstanding issues will be consolidated ahead of the workshop to support focused discussion and resolution. The workshop will conclude all remaining technical matters and align everyone for finalisation.
2. Vaccine
2.1 Biogénesis Bagó
On 20 March 2026, Dr BM Modisane, Chief Director: Animal Production and Health, issued a letter authorising Onderstepoort Biological Products (OBP) to proceed with the importation of 1,500,000 doses of FMD vaccine manufactured by Biogénesis Bagó.
The authorisation indicates a preference for a trivalent vaccine including SAT 1, SAT 2 and SAT 3. However, where this is not feasible, a bivalent vaccine containing at least SAT 1 and SAT 2 may be imported.
2.2 Dollvet
A total of 6,000,000 doses of the Dollvet vaccine have been approved for import by Dunevax under a Section 21 authorisation.
The doses will be imported in three batches of 2,000,000 each. The next consignment of 2,000,000 doses is expected in the third week of April, with the remaining two batches to follow.